In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

被引：6
作者：
VanDevanter, Donald R. [1 ]
Van Dalfsen, Jill M. [2 ]
Burns, Jane L. [3 ,4 ]
Mayer-Hamblett, Nicole [4 ,5 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Pediat, Cleveland, OH 44106 USA
[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA
[3] Univ Washington, Seattle Childrens Hosp, Infect Dis, Seattle, WA 98195 USA
[4] Univ Washington, Pediat, Seattle, WA 98195 USA
[5] Seattle Childrens Res Inst, Biomed Stat, Seattle, WA 98101 USA
来源：
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2015年 / 4卷 / 02期
关键词：
cystic fibrosis; initial P aeruginosa; susceptibility;
D O I：
10.1093/jpids/pit052
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.
引用
收藏
页码：151 / 154
页数：4
相关论文
共 50 条
  • [31] Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Gherardi, Giovanni
    Linardos, Giulia
    Pompilio, Arianna
    Fiscarelli, Ersilia
    Di Bonaventura, Giovanni
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (03) : 297 - 303
  • [32] Antimicrobial susceptibility testing of cystic fibrosis and non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa: a comparison of three methods
    Bradbury, R. S.
    Tristram, S. G.
    Roddam, L. F.
    Reid, D. W.
    Inglis, T. J. J.
    Champion, A. C.
    [J]. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2011, 68 (01) : 1 - 4
  • [33] Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics
    Ekkelenkamp, Miquel B.
    Canton, Rafael
    Diez-Aguilar, Maria
    Tunney, Michael M.
    Gilpin, Deirdre F.
    Bernardini, Francesca
    Dale, Glenn E.
    Elborn, J. Stuart
    Bayjanov, Jumamurat R.
    Fluit, Ad
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (02)
  • [34] Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
    Okur, Dicle Sener
    Yuruyen, Caner
    Gungor, Ozge
    Aktas, Zerrin
    Erturan, Zayre
    Akcakaya, Necla
    Camcioglu, Yildiz
    Cokugras, Haluk
    Koksalan, Kaya
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 675 - 685
  • [35] Typing of Pseudomonas aeruginosa in cystic fibrosis patients: comparison of genotype and antimicrobial susceptibility
    Tomic, Viktorija
    Ursic, Viktor
    [J]. ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (09): : 623 - 627
  • [36] Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates
    Opperman, Michael J.
    Shachar-Hill, Yair
    [J]. METABOLIC ENGINEERING, 2016, 38 : 251 - 263
  • [37] Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis
    Kanwar, Neena
    Harrison, Christopher J.
    Pence, Morgan A.
    Qin, Xuan
    Selvarangan, Rangaraj
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 105 (04)
  • [38] Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis
    L. Dales
    W. Ferris
    K. Vandemheen
    S. D. Aaron
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 1275 - 1279
  • [39] Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
    Lopez-Causape, Carla
    de Dios-Caballero, Juan
    Cobo, Marta
    Escribano, Amparo
    Asensio, Oscar
    Oliver, Antonio
    del Campo, Rosa
    Canton, Rafael
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (03) : 334 - 341
  • [40] Pseudomonas aeruginosa and cystic fibrosis:: non-antibiotic strategy
    Foucaud, P.
    de Truchis, A.
    Tassin, E.
    Allouch, P.
    Pangon, B.
    [J]. ARCHIVES DE PEDIATRIE, 2006, 13 : S44 - S47
12345